NewAmsterdam Pharma Co. NV (NAMS)
33.76
-0.38
(-1.13%)
USD |
NASDAQ |
May 19, 16:00
33.76
0.00 (0.00%)
After-Hours: 16:03
NewAmsterdam Pharma Profit Margin (Quarterly) : -1.59K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| uniQure NV | -1.50K% |
| ProQR Therapeutics NV | -658.3% |
| argenx SE | -- |
| Pharming Group NV | -7.20% |
| Arcutis Biotherapeutics, Inc. | -10.72% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.28% |
| Return on Assets | -27.12% |
| Return on Invested Capital | -29.27% |
| Gross Profit Margin (Quarterly) | 97.96% |
| Operating Margin (Quarterly) | -1.92K% |
| Return on Net Operating Assets | -1.82K% |